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OBJECTIVE: To study the relationship between complaints 
of xerostomia and salivary performance and food avoidances 
in four geriatric groups chosen to reflect a broad spectrum of 
individuals along the health-disease continuum. To deter- 
mine whether xerogenic medications taken by these individ- 
uals could be associated with either complaints of xerostomia 
or with food avoidances. 
DESIGN. Cross-sectional survey. Clinical examinations and 
interview. 
SETTING: A VA dental clinic and a retirement home. 
PATIENTS AND OTHER PARTICIPANTS: Subjects were 
529 individuals older than 56 years of age, living both in 
institutions and in the community (average age 70 years). 
Two hundred eight persons were recruited from a VA Dental 
Clinic, 114 from a residential retirement home, and 132 from 
a nursingllong-term-care facility; 75 were from an acute care 
ward and had a diagnosis of a cerebral vascular accident or 
other neurological condition. 
OUTCOME MEASURES Prevalence of xerostomia, dental 
morbidity, salivary flow, and food avoidances. 
RESULTS: About 72% of the subjects experienced xerosto- 
mia sometime during the day. Stimulated salivary flow was 
found to be significantly lower in individuals who com- 
plained of xerostomia than in those who did not. Fifty-five 
percent of participants reported using one or more xerogenic 
medications, with an 86% prevalence in the nursingllong- 
term-care facility. Individuals with xerostomia had difficulty 
in chewing and in starting a swallow and were significantly 
more likely to avoid crunchy foods such as vegetables, dry 
foods such as bread, and sticky foods such as peanut butter in 
their diets. Specific medications such as the inhalants iprat- 
ropium and triamcinolone and the systemic agents oxybuty- 
nin and triazolam could be statistically associated with xer- 
ostomia and/or low salivary flow, and/or specific food 
avoidances. 
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CONCLUSION Xerostomia apparently affects the ability to 
chew and start a swallow. This leads to avoidance of certain 
foods, which raises the possibility that xerostomia could 
contribute to undernutrition in older persons. The topically 
applied ipratropium and triamcinolone and the systemic 
agents amitriptyline, oxybutynin and triazolam could be 
statistically associated with one or more complaints of xer- 
ostomia. J Am Geriatr SOC 43:401407, 190. 
oor dental health, as measured by the number of missing P teeth and/or the number of decayed or periodontally 
diseased teeth, can affect dietary choices with resultant ad- 
verse nutritional consequences.' This problem is potentially 
important in older persons, where the prevalence of oral/ 
dental problems is Sullivan and colleagues have 
shown that poor oral hygiene,' xerostomia, and the inability 
to chew, among other oral conditions, were the best predic- 
tors of significant involuntary weight loss in the previous year 
among a population of frail older persons. In related studies, 
weight loss in the year before admission was one of the 
strongest predictors of subsequent in-hospital morbidity and 
mortality,* and involuntary weight loss was a strong predic- 
tor of 1-year postdischarge rn~r ta l i ty .~  
Xerostomia is a common complaint of older people and 
is usually associated with reduced salivary f l o ~ . ' ~ - ' ~  While 
some cases of xerostomia are related to auto-immune dis- 
eases such as Sjogren's ~yndrome, '~  and others are secondary 
to irradiation treatment of oral  neoplasm^,'^ the majority of 
the cases appear to be related to the usage of certain medica- 
tions.'5-'8 More than 400 medications have been cited as 
xerostomia-inducing or xerogenic drugs," but with the ex- 
ception of tricyclic antidepressants,20 anticholinergic agents, 
certain psychotrophic medications and antihistamines, and 
possibly diuretics:' most of the evidence linking a particular 
medication with xerostomia is anecdotal. In addition, several 
studies have shown that the number of medications used by 
the individual per day, regardless of whether they are xero- 
genic, can be associated with x e r ~ ~ t ~ m i a . ' ~ ~ ~ ~ ~ ~ ~  
The aim of the present investigation was to study the 
prevalence of complaints of xerostomia in four geriatric 
groups chosen to reflect a broad spectrum of individuals 
along the health-disease continuum (Loesche et al., unpub- 
lished data, 1994). We then determined whether xerostomia 
could be associated with reduced salivary performance and 
with the avoidance of various types of food. We also investi- 
gated which xerogenic medications taken by these individuals 
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could be associated with either complaints of xerostomia or 
with avoidance of certain types of food. 
MATERIALS AND METHODS 
Sample Population 
Subjectdpatients were chosen with the intention of hav- 
ing groups with different medical backgrounds. All partici- 
pants were at least 56 years of age (average age was 70 years) 
and signed a consent form approved by an institutional 
review board at both the University of Michigan School of 
Dentistry and the Ann Arbor Veterans Affairs Medical Cen- 
ter. The characteristics of these populations have been de- 
scribed elsewhere and will be briefly summarized (Loesche et 
al., unpublished data, 1994). 
Independent Living Groups 
This group consisted of 208 individuals recruited from 
the VA Dental Clinic and 114 individuals recruited from 
either the Glacier Hills Retirement Center, Ann Arbor, Mich- 
igan or from the Turner Geriatric Clinic at the University of 
Michigan Medical Center, Ann Arbor, Michigan. Ninety- 
four percent of the VA subjects were male, and 94% were 
white. Their average age was 67.8 years 5 5.1 years. Thirty 
percent of the non-VA subjects were male and 98% were 
white. Their average age was 78 2 8.5 years. Because of these 
differences in age and gender, two separate independent 
living groups were established (Loesche et al., unpublished 
data, 1994). 
Dependent Living Groups 
The nursing home group consisted of 122 residents of the 
long-term-care facility of the VA Hospital and 10 residents of 
the Glacier Hills Nursing Home. Ninety-two percent of the 
Nursing Home group were males, and 89% were white. 
Their average age was 70 2 7.2 years. 
The hospitalized group consisted of 75 VA patients, who 
had been admitted to the acute care unit with a diagnosis of a 
cerebral vascular accident or other neurological condition. 
About 90% of these individuals had been in an independent 
living status before their admission. One hundred percent of 
the Hospitalized group were males, and 81% were white. 
Their average age was 67 2 6.0 years. 
Questionnaire 
All participants were interviewed by trained interviewers 
who used a structured questionnaire to elicit information 
about demographic characteristics, medical and dental his- 
tory, use of medications, complaints of xero~tomia,2~ and 
various food avoidances (questionnaire available upon re- 
quest). The questionnaire was pretested for comprehension in 
a subsample of older individuals. In a few cases, mostly in the 
Hospitalized group, the information was obtained with the 
assistance of a relative. The interview lasted from 1 to 1’12 
hours, and provided detailed information relative to the 
subject’s eating habits, food and liquid preferences, avoid- 
ance of food types, oral hygiene habits, complaints of a dry 
mouth (xerostomia), swallowing complaints, medical his- 
tory, and usage of prescription medications. We asked the 
subjects questions regarding the time of the day in which they 
experienced a dry mouth and then questions regarding the 
amount of saliva they perceived. The questions on xerosto- 
mia were again asked by the dentist when the subjects had 
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their dental examination. Only those subjects who answered 
yes to the xerostomia questions on both occasions were 
considered as having xerostomia for our analysis. 
For VA participants, the reported current use of medica- 
tions was compared with the computerized pharmacy records 
maintained by the Ann Arbor VA Medical Center. For the 
non-VA participants the individual was asked to bring all 
medications currently being taken, to the interview, and only 
these medications were recorded on our forms. Medications 
were identified as xerogenic using the PDR Drug Interactions/ 
Side Effectdndications software program version 2.0 (Physi- 
cian’s Desk Reference, Medical Economical Data Inc., 
Montvale NJ). 
Dental Examination 
All VA patients were examined by the same clinician/ 
dental assistant team at the VA dental facility. All non-VA 
patients were examined by a second cliniciatddental hygienist 
team using the dental facility at the Glacier Hills Retirement 
Center. Both teams were initially calibrated by the same 
individual (WB) and were recalibrated semiannually. The 
number of teeth that were present and the number of de- 
cayed/missing/filled teeth and surfaces (DMF teeth, DMF 
surfaces) were recorded on standardized forms.6 The pres- 
ence of any fixed or removable prostheses, dentures or im- 
plants was recorded. Edentulousness was defined for our 
analysis as the absence of natural teeth and did not take into 
account whether dentures were present. Approximately 90% 
of the edentulous individuals had dentures available. 
Saliva 
Whole saliva was stimulated by swabbing the tongue 
with a 2% citric acid solution three times at 30-second 
 interval^.'^ During the next minute, the patients swallowed 
the first flow of saliva containing the citric acid. Thereafter 
the stimulated saliva was collected over a 5-minute period by 
asking the patients to tilt their head forward and to spit their 
saliva into a graduated, preweighed, conical tube. If the 
patient was unable to provide about 1 mL of saliva after 5 
minutes, hdshe was given a default value of <0.2 mUmin. 
All VA Hospitalized patients had their saliva collected by a 
suction procedure:’ as it was not possible for them to spit. 
The amount of saliva, as determined gravimetrically, the 
length of collection, and the time of day of the collection were 
also recorded. The minor salivary gland output was mea- 
sured as the degree of wetness present in specially prepared 
standardized cellulose stripsF6 These strips were individually 
placed on the hard palate, the buccal mucosa, and the inside 
lip and were allowed to absorb moisture for 30 seconds. The 
wetness was measured using a PeriotronTM instrument that 
was calibrated each day against a known volume of serum. 
The findings were reported as FUmin for each location, and 
the sum of the three intraoral locations was reported as the 
minor salivary gland output. 
Statistical Analysis 
If the attained probability of the overall comparisons for 
any given parameter was less than P = .05, then pair-wise 
comparisons were performed using Fisher’s Exact test for 
categorical variables at two levels. The large number of 
comparisons being made caused us to accept a P < .01 as 
being significant for the pairwise comparisons. Significance in 
those parts of Tables 2 to 4 that illustrate discrete 2x2 
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associations was obtained using Fisher’s Exact Test. The 
underlying differences between groups for the continuous 
variables in Tables 3 and 4 were found using the nonpara- 
metric Wilcoxon rank-sum test. This nonparametric test was 
used because of the lack of a normal distribution in the 
parameters under investigation. 
RESULTS 
There were no significant differences between the four 
groups when complaints of xerostomia were compared 
(Table 1). About 72% of the subjects experienced xerostomia 
at  some time during the day, with about 46% reporting this 
complaint either in the morning or at  night. Complaints in the 
evening were significantly higher for the Hospitalized pa- 
tients. Only 13% of the participants had complaints when 
eating (Table 1). There was no effect of age on the complaint 
of xerostomia; both complainers and noncomplainers aver- 
aged 70.3 to 70.7 years in age. There was no relationship 
between edentulousness and xerostomia, as 30% of both the 
complainers and noncomplainers were edentulous. There 
was no obvious effect of gender because the mostly female, 
non-VA subjects did not have a significantly lower level of 
complaints than did the male VA subjects. Because of these 
similarities, the four groups were combined for the subse- 
quent analysis of xerostomia. 
A complaint of xerostomia at  any time of the day was 
associated with a significant reduction in both stimulated 
salivary flow (0.6920.35 mYmin vs 0.58 5 0.31 mumin, 
P < .001 Wilcoxon rank sum test), and in minor salivary 
gland output (5.8 2 2.3 pUmin vs 5.3 2 2.5 pUmin, 
P = .03). A complaint of xerostomia while eating was asso- 
ciated with the greatest reduction in stimulated salivary flow 
(0.63 -t 0.33 mumin vs 0.41 -t 0.22 mumin), but with the 
smallest reduction in minor salivary gland output (5.5 pU 
min vs 5.1 pUmin). We chose “xerostomia in the morning” 
as the complaint of reference for all subsequent analysis 
because this complaint was the most frequently reported and 
because the magnitude of difference between complainers 
and noncomplainers in regard to stimulated salivary flow 
(0.12 mumin),  and minor salivary gland output (0.9 p U  
min), was the greatest in individuals with this complaint. 
We determined whether this complaint of xerostomia in 
the morning could be associated with oral problems relating 
to dryness. The individuals who complained of xerostomia 
were 14.1 times more likely to state that their cheeks stuck to 
their teeth (Table 2). These individuals were significantly 
more likely to report that food sticks in their throat and that 
they had difficulty in chewing, in starting a swallow, and in 
swallowing (Table 2). They were 6.4 times more likely to 
report that they had too little saliva, and their mouths were 
5.2 times more likely to be dry when eating. Perhaps to 
compensate for this dryness, they were 2.1 times more likely 
to report that they sip liquids to help them swallow dry foods. 
These findings suggested that an individual with a com- 
plaint of xerostomia might have problems eating because of 
these difficulties associated with chewing and swallowing. 
We asked all subjects whether there were certain foods that 
s/he avoided in their diets. Thirty-one percent of the individ- 
uals with a complaint of “xerostomia in the morning” stated 
that they avoided one or more food types, a prevalence that 
was significantly higher than the response rate of 18% re- 
ported by people without the complaint (Table 2). The indi- 
viduals who complained of xerostomia, relative to the non- 
xerostomic individuals, were significantly more likely to 
avoid crunchy foods such as carrots and sticky foods such as 
peanut butter. There was also a tendency to avoid dry foods 
such as bread. 
We determined whether the complaint of xerostomia 
could be associated with the usage of putative xerogenic 
medications. About 46 to 48% of the Independent Living 
subjects, 55% of the Hospitalized patients, but 86% of the 
Nursing Home patients used one or more xerogenic medica- 
tions. The higher frequency of usage in the Nursing Home 
patients was significant when compared with the other 
groups, i.e., P < .001. However, despite this higher usage of 
putative xerogenic medications in the nursing home, these 
individuals did not have a significantly higher prevalence of 
xerostomic complaints (Table 1). The individuals who used 
xerogenic medications were 2.1 times more likely to have a 
complaint of xerostomia in the morning, than individuals 
who did not use xerogenic medications (P < 0.001). These 
individuals also had significantly less stimulated salivary 
flow, but there was no apparent effect of the usage of 
xerogenic medications on the minor salivary gland output 
(Table 3). Individuals who used xerogenic medications were 
2.5 times more likely to be edentulous and, among the den- 
tate individuals, were 2.7 times more likely to have fewer 
than 10 teeth, compared with those individuals who did not 
use xerogenic medications (Table 3). 
Table 1. Frequency of Complaints of Xerostomia Among the Various Geriatric Groups 
Independent Living Dependent Living All 
Subjects non-VA VA Nursing Home Hospitalized 







72%* 68%* 72%‘ 71 %* 
46 48 40 51 
31 27 28 33 
32 27 26 35 
45 43 42 49 







‘Proportion of individuals in each group who gave a positive response for complaint. 
‘Any time would include individuals who had one or more complaints related to the five temporal periods listed. 
‘Overall difference is significant, P = 0.004, due primarily to high proportion of complaints in hospitalization patients relative to both independent living groups. 
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Table 2. Relationship Between Complaints of Xerostomia in the Morning and Complaints Relative to Oral Dryness and Eating and 
Salivary Hypofunctions 
Complaints of Xerostomia 
in Morning 
Odds Ratio 
No (281)* Yes (242) Significance* (95% CI) 
Oral dryness 
Cheeks stick to teeth 1.1 %* 13.5% <0.001 14.1 (4.2,46.7) 
Food stick in throat 17.3 34.2 <0.001 2.5 (1.6,3.7) 
chewing 12.2 27.2 <0.001 2.7 (1.7,4.3) 
starting a swallow 8.7 18.9 <0.001 2.4 (1.4,4.2) 
in swallowing5 19.0 34.8 <0.001 2.3 (1.5, 3.4) 
Difficulty in 
Subjective measures of salivary 
hypofunction 
Sip liquids5 26.8 43.9 <0.001 2.1 (1.5, 3.1) 
Mouth dry when eating5 5.1 21.8 <0.001 5.2 (2.8,9.7) 
Is saliva too little5 7.9 35.6 <0.001 6.4 (3.9, 10.7) 
Any food 17.7%* 31.5%* <0.001 2.1 (1.4,3.2) 
Chewy (beef)" 12.3 17.3 NS 
Dry (bread) 5.4 10.0 0.065 2.0 (1 .O, 3.8) 
Crumbly (Cake) 3.6 6.3 NS 
Sticky (peanut butter) 2.9 8.0 0.01 6 2.9 (1.2,6.8) 
Types of foods avoided 
Crunchy (carrot) 9.4 17.7 0.006 2.1 (1.2,3.5) 
'Number of subjects in each response group. 
'Significance - Fisher's Exact test - 2 tail. 
*Percentage of subjects who responded yes to question. 
SQuestions related to salivary hypofunction. See ref. 25. 
"Example of food type explained to patient when asking question in food avoidance. 
Table 3. Relationship Between Usage of Xerogenic Medications and Salivary Function and Dental Status 
Simulated Minor Salivary 
Usage of Xerogenic No. of Salivary Flow Gland Output % % Dentate 
Medications Subjects rnVmin pUmin. Edentulous 2 10 teeth 
No 222 0.64 5 0.34 5.2 2 2.3 20 72% 
Yes 307 0.58 2 0.32 5.5 2 2.6 37 49% 
Odds Ratio (95% 2.5 (1.6,3.7) 2.7 (1.8,4.0) 
Significance P = 0.025" NS P < .001t P < .001+ 
confidence interval) 
'Wilcoxon rank-sum test. 
'Fisher's Exact Test. 
We next examined the relationship between the reported 
usage of individual putative xerogenic medications with the 
complaints of xerostomia and with the measured salivary 
parameters. The 20 xerogenic medications used most fre- 
quently by these subjects were examined for their association 
with any complaint of xerostomia or with any problems of 
salivary gland performance. The three most frequently pre- 
scribed putative xerogenic medications, diltiazem (n = 55 
subjects), diphenhydramine (n = 49 subjects), and triam- 
terenehydrochlorothiazide (n = 39 subjects) could not be 
associated with any complaint of xerostomia or with any 
form of reduced salivary gland performance. Likewise, the 
usage of verapamil (n = 20 subjects), timolol (n = 21 sub- 
jects), hydroxyzine (n = 12 subjects), clonidine (n = 11 
subjects), metoprolol (n = 11 subjects), guaifenesin (n = 10 
subjects), and thiethylperazine (n = 9 subjects) could not be 
associated with any complaint of xerostomia or with reduced 
salivary flow. However, with these latter medications the 
number of subjects may have been too small to draw any 
conclusions. 
Seven medications, ipratropium (Atrovent), triamcin- 
olone (Azmacort), oxybutynin (Ditropan), amitriptyline 
(Elavil), triazolam (Halcion), sucralfate (Carafate), and ibu- 
profen (Motrin) could be significantly associated with com- 
plaints of xerostomia at one or more times during the day 
(Table 4). The individuals who used ipratropium were 15 
times more likely to report any complaint of xerostomia than 
were individuals who did not use this bronchodilator. De- 
spite this strong association with complaints of xerostomia, 
ipratropium was not associated with a reduced stimulated 
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Table 4. Relationship Between Usage of Certain Xerogenic Medications and Complaints of Xerostomia, and Salivary Parameters 
Xerostomia Salivary Parameters 
Any Time In Morning At Night/in Dry while Too Little Stimulate MSGO 
Medication (N) ORt Sig(P)+ OR Sig(P) OR Sig(P) OR Sig(P) OR Sig(P) Sig(P)ll Sig(P)" 
evening eating (Subjective) d Xerogenic* ~~ 
lpratropium (36) 14.9 <.001 2.1 .05 2.9 <.003 3.2 .006 2.9 .005 .03$ 
Triamcinolone (1 3) 6.4 .009 4.1 .03 3.4 .06 6.2 .002 
Oxybutynin (1 8) 4.1 .01 3.2 .03 
Amitriptyline (1 8) 2.8 .04 4.9 .001 .02 .08 
Sucralfate (27) 2.9 .03 .03 
Ibuprofen (37) 2.6 .03 
Transderm-nitro (1 9) .03 
Triazolam (38) 2.2 .03 .01 
Fluoxetinne (9) .02 
*Number of subjects using medication. 
+Sig = significance using Fisher's Exact Test; OR = Odds Ratio. All values are significant in that the 95% confidence interval does not include 1.0. 
'Higher in group taking ipratropium. 
SMSGO = minor salivary gland output. 
"Differences between subjects using and not using medication significant using Wilcoxon rank sum test. 
salivary flow, and there was actually a significant increase in 
the minor salivary gland output (Table 4). The patients who 
used ipratropium were more likely to be edentulous, and if 
dentate, to have fewer than 10 teeth (data not shown). 
Individuals who used the other inhalant on this list, triamci- 
nolone, were 6 times more likely to report a complaint of 
xerostomia in the morning and to state that they had too little 
saliva (Table 4). There was no observed reduction in either 
stimulated salivary flow or in the minor salivary gland out- 
put. The subjects who used oxybutynin, triazolam, and ami- 
triptyline were significantly more likely to complain of xer- 
ostomia in the evening or at  night. The usage of sucralfate 
and ibuprofen were associated with dryness only when eat- 
ing. 
The use of triazolam, amitriptyline, fluoxetine, and su- 
cralfate was associated with a significantly reduced stimu- 
lated salivary flow, but with the exception of amitriptyline, 
there was no effect on the minor salivary gland output (Table 
4). Although none of the nine individuals who used fluoxetine 
had a complaint of xerostomia, there was a significantly 
lower stimulated salivary flow in these patients. Transderm- 
nitro and, to a lesser extent, amitriptyline were associated 
with lower minor salivary gland output (Table 4). 
We next determined whether any of these 20 putative 
xerogenic medications could be associated with any reported 
food avoidances. Individuals using ipratropium were signifi- 
cantly more likely to avoid one or more types of food (OR = 
2.28, P = .04), especially chewy (meats) (OR = 3.2, P = 
.005) and crunchy (carrots) (OR = 2.8, P = .02) types of 
food. The individuals taking amitriptyline were 7 times more 
likely to avoid chewy foods (P = .007), and those using 
diphenhydramine were 2.4 times more likely to avoid 
crunchy foods (P = .02). 
DISCUSSION 
The 72% prevalence of complaints of xerostomia at any 
time during the day reported by the participants in this 
investigation (Table 1) is higher than the prevalences of 10 to 
55% found by other investigat~rs.'~-'~~'~~'' This could re- 
flect the fact that participants were asked multiple questions 
about the time of day in which they experienced mouth 
dryness, were queried about xerostomia on two separate 
occasions, and that the xerostomia questions were positioned 
after those questions related to thirst. Our positive xerosto- 
mia responses would also have been increased by the inclu- 
sion of hospitalized patients with a swallowing problem. 
Eighty-two percent of these patients reported having a com- 
plaint of xerostomia (Table l ) ,  but as they comprised only 
14% of our total population, they alone, could not account 
for the high prevalence of xerostomia noted. 
Xerostomia has been associated with various oraYdental 
problems, such as an increased prevalence of d e ~ a y , ' ~ ~ ~ '  
edentulousness?' and salivary h y p o f u n ~ t i o n . ' ~ ~ ~ ~  We ob- 
served similar associations in that our subjects with com- 
plaints of xerostomia had significantly more decayed teeth, 
(unpublished data), and reduced stimulated whole saliva and 
minor salivary gland output. Some investigators have found 
no relationship between complaints of xerostomia and stim- 
ulated salivary flow.23,24y29 Several investigators have sug- 
gested that resting whole saliva p r o d ~ ~ t i o n , Z ~ ~ ~ ~ ~ ~ '  which has 
a large contribution from the submandibular gland and lesser 
amounts from the parotid, sublingual and the various minor 
salivary glands:0J' is the most reliable objective correlate of 
xerostomia. Resting whole saliva is difficult to measure, es- 
pecially in the sick and in older persons, and because of this is 
often not included in investigations of ~ e r o s t o m i a . ~ ~ ~ ~ ~  We 
have used the minor salivary gland output as a surrogate for 
resting whole saliva because its collection is simple and re- 
producible.26 Although the minor salivary gland output may 
only comprise up to 8% of the resting salivary f lo~:~ ,~ '  we 
found that it was significantly associated with complaints of 
xerostomia. This suggests that the minor salivary gland out- 
put may serve as a surrogate for resting whole saliva in 
studies involving xerostomia. 
Complaints of xerostomia in our subjects could be sig- 
nificantly associated with a positive response to a series of 
questions that have been shown to significantly correlate with 
hypofunction of the salivary glands,Z4 (Table 2). The xeros- 
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tomic individuals were 6.4 and 5.2 times more likely to give a 
positive response to questions about having too little saliva 
and having a dry mouth when eating, but they were 14 times 
more likely to state that their cheeks stuck to their teeth or 
dentures (Table 2). As such, these three questions might 
reliably identify individuals with salivary gland hypofunc- 
tion. 
Individuals with xerostomia in the morning reported 
having difficulty in chewing, in starting a swallow, and in 
swallowing (Table 2). This could influence their choice of 
foods, and, indeed, individuals with a complaint of xerosto- 
mia were significantly more likely to avoid crunchy foods 
such as carrots and sticky foods such as peanut butter (Table 
2). Other investigators have shown that xerostomia can be 
associated with undernutrition among both institutionalized 
and independent-living older persons 34 and that xerostomia 
is one of the common oral conditions associated with signif- 
icant involuntary weight loss among frail older people.' Our 
observations on food avoidances, albeit indirect measures of 
dietary intake, support the hypothesis that a complaint of 
xerostomia may contribute to undernutrition in older per- 
sons. 
These adverse medical outcomes associated with com- 
plaints of xerostomia warrant efforts to prevent and treat this 
condition. More than 400 medications are believed to be 
xerogenic," which suggests that one approach to prevent or 
to reduce xerostomia would be to substitute a nonxerogenic 
medication for a xerogenic medication whenever the medical 
condition permits such an option. 
We looked at  the relationship between the 20 most 
frequently used medications and the various oravdental pa- 
rameters under investigation. The confounding effect of the 
use of more than one xerogenic medication, or of varying 
dosages of the medication and patient compliance, were not 
addressed. Nine medications could be associated significantly 
with either a complaint of xerostomia or with diminished 
salivary gland performance. Triazolam, amitriptyline, and 
sucralfate, which could be significantly associated with both 
a complaint of xerostomia and with a reduction in stimulated 
salivary flow, were the most xerogenic of these medications. 
Of these, amitriptyline and triazolam, which have been 
grouped by several authors with antipsychotic, hypnotic, and 
psychotropic medications, have frequently been associated 
with x e r ~ ~ t o m i a . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ' - ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~  There is apparently 
little data that associates sucralfate with decreased salivary 
gland performance.2' 
Ipratropium bromide and triamcinolone acetonide, used 
as inhalants in the treatment of emphysema and asthma, were 
significantly associated with complaints of xerostomia and 
with the patients own assessment that they had too little 
saliva (Table 4). However, neither agent significantly affected 
stimulated salivary flow and perhaps, because of the mucosal 
dryness, there was a compensatory increase in the minor 
salivary gland output when ipratropium was used (Table 4). 
Oxybutynin and ibuprofen could be associated with com- 
plaints of xerostomia but not with any decrease in salivary 
gland performance. Fluoxetine, although used by only nine 
subjects, could be associated with a reduction in stimulated 
salivary flow. Previously we had found that fluoxetine signif- 
icantly reduced stimulated salivary flow in young, bulimic 
women.37 This would suggest that the substitution of fluox- 
etine for any of the tricyclic antidepressants may not improve 
salivary flow. 
When considering the relationship between drugs and 
salivary glands, it is necessary to recognize the difference 
between medications that cause the sensation of dryness, but 
which may have no effect on the salivary glands, and those 
medications that can actually inhibit or alter salivary secre- 
tions21 Other investigators have noted that oral dryness does 
not reliably indicate decreased salivary o ~ t p u t . ~ ' ? ~ ' * ~ ~  W ith 
ipratropium bromide and triamcinolone acetonide, this dif- 
ference was clearly observed as these topical agents caused 
dryness of the oral surfaces, yet had no discernible effect on 
salivary flow. In this case, the absence of an effect probably 
reflected that these topically delivered agents did not achieve 
systemic levels that could influence salivary secretion. 
It was of interest to determine whether any of the twenty 
most frequently used medications could be associated with a 
history of food avoidances. Ipratropium could be associated 
with the avoidance of chewy and crunchy foods. This obser- 
vation suggests that this topically applied agent was causing 
either a degree of dryness or a sense of dryness that made 
certain foods uncomfortable to eat, despite the fact that the 
salivary flow was not obviously reduced. Individuals who 
used amitriptyline were 7 times more likely to avoid chewy 
foods such as meat. Diphenhydramine, a putative xerogenic 
medication, for which we could find no association with a 
complaint of xerostomia or of a reduced salivary flow, was, 
however, associated with an avoidance of crunchy type 
foods. None of the medications associated with a reduction in 
salivary flow, with the exception of amitriptyline, could be 
associated with the avoidance of any types of food, suggest- 
ing that the sense of dryness, rather than a lack of saliva, was 
the most important consideration in the subject's food pref- 
erences. In the case of amitriptyline, there were also com- 
plaints of xerostomia, reinforcing the suggestion that xeros- 
tomia per se was the main determinant of food avoidances. 
The present findings confirm other studies that show that 
complaints of xerostomia are common among older per- 
and that these complaints can be associated 
with the use of one or more medications that are considered 
to be xer~genic.'~.' 1315-18-21 Specific medications were iden- 
tified that appeared more likely to be associated with xeros- 
tomia than others. Of these, the topically applied iprat- 
ropium and triamcinolone, both inhalants used for bronchial 
dilation, and the systemic agents oxybutynin, triazolam, and 
amitriptyline, could be statistically associated with one or 
more complaints of xerostomia. Of these, only triazolam and 
amitriptyline could be associated with a reduced salivary 
flow. 
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